NCT06097780View on ClinicalTrials.gov

Efficacy and Safety of NestaCell® in Huntington's Disease

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 8, 2024

Primary Completion Date

September 8, 2025

Study Completion Date

February 9, 2026

Conditions

Huntington Disease

Interventions

GENETIC

NestaCell®

Human Dental Pulp Stem Cells (hDPSCs).

All Listed Sponsors

collaborator

Cellavita Pesquisa Científica Ltda

OTHER

lead

Azidus Brasil

INDUSTRY